Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) EBT Margin (2016 - 2025)

Veracyte (VCYT) has disclosed EBT Margin for 14 consecutive years, with 28.89% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 2599.0% to 28.89% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 13.19% through Dec 2025, up 741.0% year-over-year, with the annual reading at 13.19% for FY2025, 741.0% up from the prior year.
  • EBT Margin hit 28.89% in Q4 2025 for Veracyte, up from 14.32% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 28.89% in Q4 2025 to a low of 124.41% in Q1 2021.
  • Historically, EBT Margin has averaged 12.23% across 5 years, with a median of 9.49% in 2023.
  • Biggest five-year swings in EBT Margin: tumbled -8677bps in 2021 and later surged 10307bps in 2022.
  • Year by year, EBT Margin stood at 16.73% in 2021, then soared by 75bps to 4.25% in 2022, then crashed by -630bps to 31.02% in 2023, then skyrocketed by 109bps to 2.9% in 2024, then soared by 896bps to 28.89% in 2025.
  • Business Quant data shows EBT Margin for VCYT at 28.89% in Q4 2025, 14.32% in Q3 2025, and 0.96% in Q2 2025.